Antibacterial agents agent in preclinical development

This is the World Health Organization’s first comprehensive overview of the preclinical antibacterial pipeline to date based on publicly available data on each included project. This report and the respective WHO database capture 252 antibacterial agents in development targeting the pathogens on the WHO priority pathogens list, Mycobacterium tuberculosis and Clostridioides difficile. The preclinical pipeline is dynamic and scientifically diverse, with agents being developed in many parts of the world to prevent and treat drug-resistant bacterial infections.

 

Smart Innovations   Back